WHEREAS, More than 1.6 million Americans suffer from Crohn's
disease and ulcerative colitis; and
WHEREAS, Ten percent of persons affected by Crohn's disease
and ulcerative colitis are children under 18 years of age; and
WHEREAS, Crohn's disease and ulcerative colitis affect people
of all ages, but they are primarily diseases of adolescents and
young adults, affecting mainly persons between 15 and 35 years
of age; and
WHEREAS, The diseases affect males and females equally; and
WHEREAS, Symptoms of Crohn's disease and ulcerative colitis
include abdominal pain, fever, diarrhea, loss of appetite and
rectal bleeding; and
WHEREAS, There is no known cure for Crohn's disease and
ulcerative colitis, only medication to suppress inflammation;
and
WHEREAS, Approximately 23% to 45% of people with ulcerative
colitis and up to 75% of people with Crohn's disease will
eventually require surgery; and
WHEREAS, The Crohn's and Colitis Foundation of America, also
known as the CCFA, works diligently to research the diseases,
provide information and aid to patients and increase national
awareness of Crohn's disease and ulcerative colitis; and
WHEREAS, The National Institute of Diabetes and Digestive and
Kidney Diseases also conducts and supports research into many
kinds of digestive disorders, including Crohn's disease; and
WHEREAS, "Crohn's Disease and Ulcerative Colitis Awareness
Month" increases public awareness of Crohn's disease and
ulcerative colitis patients' circumstances, acknowledges the
impact of the diseases on patients and families and recognizes
research for treatment and a cure for Crohn's disease and
20160SR0342PN1701 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30